Suchergebnisse - "Ritonavir"

PubPharm (392)

21

Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia

enthalten in: AIDS (London, England) | 2018

von Leyes, P. | Cofan, M. | González-Cordón, A. | +9

22

HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy

enthalten in: AIDS (London, England) | 2018

von Dijkstra, M. | van Lunsen, R. | Kooij, K. | +7

23

Protease inhibitors and preterm delivery : another piece in the puzzle

enthalten in: AIDS (London, England) | 2018

von Favarato, G. | Townsend, C. | Bailey, H. | +4

24

Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case

enthalten in: AIDS (London, England) | 2018

von Yoshimura, Y. | Miyata, N. | Komatsu, H. | +1

25

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

enthalten in: AIDS (London, England) | 2017

von Gatell, J. | Assoumou, L. | Moyle, G. | +15

CommentIn: AIDS. 2017 Nov 28;31(18):2547-2549. - PMID 29120900

26

Conference on Retroviruses and Opportunistic Infections 2017 highlights

enthalten in: AIDS (London, England) | 2017

von Harper, K.

27

Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin : boosters are not always equal

enthalten in: AIDS (London, England) | 2017

von Tseng, A. | Luetkehoelter, J. | Walmsley, S.

28

Efavirenz is associated with higher bone mass in South African children with HIV

enthalten in: AIDS (London, England) | 2016

von Arpadi, S. | Shiau, S. | Strehlau, R. | +7

29

Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir

enthalten in: AIDS (London, England) | 2016

von Smolders, E. | Kanter, C. | Grintjes, K. | +5

30

Protease inhibitor monotherapy for long-term management of HIV infection

enthalten in: AIDS (London, England) | 2016

von Harper, K.

CommentOn: Lancet HIV. 2015 Oct;2(10 ):e417-26. - PMID 26423649